Breaking ‘female health’ taboos in IP
Battling sexism in life sciences
saamoP / Shutterstock.com
Technology is continuing to transform women’s healthcare and female inventors are driving the change—but more needs to be done to ensure they secure IP rights, finds Liz Hockley.
The women’s healthcare market is rapidly expanding, with an ever-growing number of startups using new technology to develop innovative ‘femtech’ products.
Femtech encompasses a wide range of technologies that address female health issues, including menstruation, fertility, pregnancy and menopause. The term was coined in 2016 by Ida Tin, the creator of period and ovulation tracker Clue, because she wanted to legitimise an area of healthcare that has historically been under-researched and under-funded.
The global femtech market is now expected to reach $75 billion by 2025, according to data agency FemTech Analytics. Many innovators are already seizing this opportunity.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at email@example.com
Femtech, women healthcare, female inventors, IP rights, Mewburn Ellis, technology, startups, innovation, patents, artificial intelligence, cancer